Living with Alpha-1
Alpha-1 can feel overwhelming, but there are ways to develop healthier habits that make managing your condition easier.
Alpha-1 can feel overwhelming, but there are ways to develop healthier habits that make managing your condition easier.
Why not give yourself a new challenge every week as you work toward more consistent wellness habits? Explore the recommendations below for simple steps you can take toward each goal. Make sure to consult with your doctor to determine what works best for you.
Living with alpha-1 isn’t easy, but you have the power to take small, meaningful steps toward a healthier life. Every step counts, and you’re not alone on this path.
Seamless support makes starting and staying on treatment easier. Shipping your medicine and scheduling and administering your infusion are all handled by the PROLASTIN DIRECT® program.
Important Safety Information
PROLASTIN®-C LIQUID is an alpha1-proteinase inhibitor (human) (alpha1-PI) indicated for chronic augmentation and maintenance therapy in adults with clinical evidence of emphysema due to severe hereditary deficiency of alpha1-PI (alpha1-antitrypsin deficiency).
Limitations of Use
PROLASTIN-C LIQUID is contraindicated in immunoglobulin A (IgA)-deficient patients with antibodies against IgA or patients with a history of anaphylaxis or other severe systemic reaction to alpha1-PI products.
Hypersensitivity reactions, including anaphylaxis, may occur. Monitor vital signs and observe the patient carefully throughout the infusion. If hypersensitivity symptoms occur, promptly stop PROLASTIN-C LIQUID infusion and begin appropriate therapy.
Because PROLASTIN-C LIQUID is made from human plasma, it may carry a risk of transmitting infectious agents, eg, viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent. This also applies to unknown or emerging viruses and other pathogens.
The most common adverse reactions during PROLASTIN-C LIQUID clinical trials in >5% of subjects were diarrhea and fatigue, each of which occurred in 2 subjects (6%).
Please see full Prescribing Information for PROLASTIN-C LIQUID.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088.
*This website is provided as a resource only and does not constitute an endorsement by Grifols of any particular content. Grifols does not review or control the content of non-Grifols websites.